These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 20019696)

  • 1. A piece in the puzzle of personalized medicine.
    Kroemer HK; Meyer zu Schwabedissen HE
    Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized medicine for patients with asthma.
    Greenberger PA
    J Allergy Clin Immunol; 2010 Feb; 125(2):305-6. PubMed ID: 20159238
    [No Abstract]   [Full Text] [Related]  

  • 3. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
    G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMET microarray technology for pharmacogenomics-based personalized medicine.
    Burmester JK; Sedova M; Shapero MH; Mansfield E
    Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving the promise of personalized medicine.
    Reynolds KS
    Clin Pharmacol Ther; 2012 Oct; 92(4):401-5. PubMed ID: 22992663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised treatment of arthritis in the next eRA.
    Tas SW
    Neth J Med; 2009 Dec; 67(11):362-3. PubMed ID: 20009111
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs, diabetes and pharmacogenomics: the road to personalized therapy.
    Watanabe RM
    Pharmacogenomics; 2011 May; 12(5):699-701. PubMed ID: 21619432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
    Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dealing with the evidence dilemma in genomics and personalized medicine.
    Khoury MJ
    Clin Pharmacol Ther; 2010 Jun; 87(6):635-8. PubMed ID: 20485318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized immunosuppressive therapy in pediatric heart transplantation: Progress, pitfalls and promises.
    Xie HG
    Pharmacol Ther; 2010 May; 126(2):146-58. PubMed ID: 20153366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacometabonomics, pharmacogenomics and personalized medicine.
    Guţiu IA; Andrieş A; Mircioiu C; Rădulescu F; Georgescu AM; Cioacă D
    Rom J Intern Med; 2010; 48(2):187-91. PubMed ID: 21428184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial pharma-Q-genomics: targeting the OXPHOS cytochrome b.
    Gómez-Durán A; Pacheu-Grau D; López-Pérez MJ; Montoya J; Ruiz-Pesini E
    Drug Discov Today; 2011 Mar; 16(5-6):176-80. PubMed ID: 21112412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics, personalized medicine, and heart failure.
    Mestroni L; Taylor MR
    Discov Med; 2011 Jun; 11(61):551-61. PubMed ID: 21712021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
    Loo TT; Ross CJ; Sistonen J; Visscher H; Madadi P; Koren G; Hayden MR; Carleton BC
    Pharmacogenomics; 2010 Sep; 11(9):1269-85. PubMed ID: 20860467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles.
    Pirmohamed M
    Clin Pharmacol Ther; 2010 Dec; 88(6):862-6. PubMed ID: 20981006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward personalized medicine in the neuropsychiatric field.
    Wong EH; Fox JC; Ng MY; Lee CM
    Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.